Inventor
CHARLOTTE MARY GRIFFITHS-JONES
Inventor
GB
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds32%
A61KPreparations for medical, dental or toiletry purposes27%
C07BGeneral methods of organic chemistry5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
PatentTitleYear
12,202,828Bicyclic heterocycle compounds and their uses in therapy202512,091,409Ether linked triazoles as NRF2 activators202411,939,321Benzolactam compounds as protein kinase inhibitors202411,866,428Bicyclic heterocycle compounds and their uses in therapy202411,643,410Bicyclic heterocycle compounds and their uses in therapy202311,603,367Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them202311,225,476Bicyclic heterocycle compounds and their uses in therapy2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to ASTEX THERAPEUTICS LTD (6)· patent assignee history
2022–2025Based in GB· patent location history
2023Patents assigned to CANCER RESEARCH TECH LTD (1)· patent assignee history
2024Patents assigned to OTSUKA PHARMA CO LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ASTEX THERAPEUTICS LTD | 6 | 2022–2025 |
| CANCER RESEARCH TECH LTD | 1 | 2023 |
| OTSUKA PHARMA CO LTD | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| GB | 7 | 2022–2025 |